Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. How we score this
1 firm currently rating it, weighted by track record.
The 1 firm with a track record here beat the S&P 42% of the time over 12 months.
Pro: see the crowd-vs-sharp split for BRK-BAnalysts rate Berkshire Hathaway Buy, with a consensus price target of $547.67, implying 6.4% upside from current levels. UBS has maintained a Buy rating consistently through August 2026, though TD Cowen initiated coverage with a Hold in July 2024. The diversified insurer trades at a trailing P/E of 12.95 with trailing revenue growth of 10% and EPS growth of 107.80% year-over-year, supported by a conservative debt-to-equity ratio of 0.17 and net margin of 22.30%.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 10, 2026 | UBS | ○ Maintained | |
| Jul 28, 2026 | UBS | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free